Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

The agency had for years said it could not conclude whether COVID-19 was the result of a lab incident or it originated in ...

General side effects: tiredness, headache, muscle pain, chills, joint pain, fever, nausea, feeling unwell, swollen lymph ...

Rising diagnoses of certain cancers in people under 50 predate the rollout of COVID-19 vaccines by decades, undermining ...

Shares of Moderna Inc. climbed nearly 1% on Friday, reaching levels last seen on Jan. 10, as retail sentiment turned ...

While the COVID-19 pandemic is behind us, conspiracy theories, much like the virus itself, haven’t gone anywhere. And the latest bizarre claim about the vaccine is, let’s just say, a bit out of the ...

Key Takeaways COVID-19 vaccine hesitancy among parents is linked to lower childhood vaccination ratesChildren whose parents refused the COVID jab were 25% less likely to be vaccinated against ...

St. Luke's argued that Glean’s request focuses on concern about bodily harm and not religious belief. The Kansas Department ...

Moderna (MRNA) stock gained in the premarket after the company received a tender to supply its COVID-19 vaccine in the EU, ...

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats ...

Studies conducted in mice have shown that the COVID-19 vaccine being developed by researchers at the University of São ...

SINGAPORE: The updated JN.1 Novavax/Nuvaxovid COVID-19 vaccine will be offered under the national vaccination programme at ...